By Karen Blum
Ensuring the way that pharmaceutical manufacturers work with specialty pharmacies, advocacy groups and patients is transparent and fair can help keep companies away from federal scrutiny and expensive legal challenges, a panel of legal experts said during Informa Connect’s 2021 Compliance Congress for Specialty Products, held virtually.
Manufacturers may choose to enter limited distribution network contracts with specialty pharmacies for particular products, knowing these